The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 06, 2015

Filed:

Mar. 14, 2013
Applicants:

Abbvie Deutschland Gmbh & Co. KG, Wiesbaden, DE;

Abbvie Inc., North Chicago, IL (US);

Inventors:

Andreas Kling, Wiesbaden, DE;

Katja Jantos, Wiesbaden, DE;

Helmut Mack, Wiesbaden, DE;

Achim Möller, Wiesbaden, DE;

Wilfried Hornberger, Wiesbaden, DE;

Gisela Backfisch, Wiesbaden, DE;

Yanbin Lao, North Chicago, IL (US);

Marjoleen Nijsen, Wiesbaden, DE;

Assignees:

AbbVie Deutschland GmbH & Co. KG, Wiesbaden, DE;

AbbVie Inc., North Chicago, IL (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/44 (2006.01); C07D 221/18 (2006.01); C07D 401/00 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 401/04 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 413/14 (2006.01); C07D 491/048 (2006.01); C07D 491/107 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); C07D 401/04 (2013.01); C07D 405/14 (2013.01); C07D 413/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 491/048 (2013.01); C07D 491/107 (2013.01);
Abstract

The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula (I) in which R, Rand n have the meanings mentioned in the claims and the description, Y is a radical of the formulae (Y1) or (Y2) where # indicates the point of attachment of Y to the pyridine ring, R, R, R, Rand m have the meanings mentioned in the claims and the description, A is (CH)with p being 1, 2, 3 or 4, where one or two hydrogen atoms may be replaced by a radical R, where A is attached to the 3- or 4-position of the pyrazole radical and Rhas the meaning mentioned in the claims and the description; Ais (CH)q with q being 0, 1, 2 or 3, where one or two hydrogen atoms may be replaced by halogen or C-C-alkyl; and Ais (CH)r with r being 0, 1, 2 or 3, where one or two hydrogen atoms may be replaced by halogen or C-C-alkyl, provided that that r+q is 2, 3, 4, 5 or 6; their tautomers, the hydrates thereof, the pharmaceutically suitable salts of the carbox-amide compounds (I), the prodrugs of (I) and the pharmaceutically suitable salts of the prodrugs, tautomers or hydrates of (I).


Find Patent Forward Citations

Loading…